Can Biomarkers Guide the Use of Neoadjuvant Chemotherapy in T2 Bladder Cancer? [electronic resource]
Producer: 20200619Description: 597-602 p. digitalISSN:- 2588-9311
- Antineoplastic Combined Chemotherapy Protocols -- economics
- Biomarkers, Tumor -- analysis
- Clinical Decision-Making -- methods
- Cystectomy
- DNA Damage
- DNA Repair
- Decision Support Techniques
- Guideline Adherence -- standards
- Humans
- Male
- Middle Aged
- Neoadjuvant Therapy -- economics
- Neoplasm Invasiveness -- pathology
- Neoplasm Staging
- Patient Selection
- Practice Guidelines as Topic
- Predictive Value of Tests
- Prognosis
- Treatment Outcome
- Urinary Bladder -- pathology
- Urinary Bladder Neoplasms -- genetics
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.